• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail
?
-

Resources for You

Xenical (orlistat) Capsules, 120 mg February 2009

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- February 2009

 

The detailed view includes drug products with safety labeling changes to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, or PATIENT PACKAGE INSERT/MEDICATION GUIDE sections. Deletions or editorial revisions made to these sections are not included in this summary. Read about the new physician labeling format.


Summary View

Sections Modified

PRECAUTIONS

  • Drug Interactions
    • Levothyroxine
      • Hypothyroidism has been reported in patients treated concomitantly with orlistat and levothyroxine.....

ADVERSE REACTIONS

  • Other Clinical Studies or Postmarketing
    Surveillance
    • Hypothyroidism has been reported in patients treated concomitantly with orlistat and
      levothyroxine.

PATIENT PACKAGE INSERT

  • What should I tell my doctor before taking XENICAL?
    • make sure your doctor knows if you are taking thyroid medicine....
  • Can I take XENICAL while taking other medications?
    • ..... XENICAL and levothyroxine should be taken at least 4 hours apart